Compound Evidence File
#EC-2026-0649
Testosterone Enanthate Raw
Filed under Raw Materials. The bureau holds 74 laboratory returns for this compound from 23 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
23 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Feb 2026 | 10 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 2 May 2026 | 5 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 6 May 2026 | 12 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Nov 2025 | 17 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 26 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Jan 2026 | 12 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 9 Nov 2025 | 20 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 5 May 2026 | 10 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 9 May 2026 | 11 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Mar 2026 | 21 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 15 Feb 2026 | 8 Mar 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Apr 2026 | 10 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Mar 2026 | 27 Jun 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.6 | 7.6 | 9.7 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.6 | 8.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.5 | 7.8 | 9.1 | 24 May 2026 | 24 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.5 | 8.5 | 8.5 | 25 Apr 2025 | 25 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.2 | 7.0 | 9.2 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.1 | 7.4 | 9.7 | 24 May 2026 | 24 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 3.8 | 3.8 | 3.8 | 27 Feb 2025 | 27 Feb 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 3.6 | 3.6 | 3.6 | 8 Jul 2025 | 8 Jul 2025 |
Open any subject to view the batch-level evidence for Testosterone Enanthate Raw alone.